HeartSciences (HSCS) vs Lifeward (LFWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences (HSCS) has outperformed Lifeward (LFWD) over the past year, losing 18.3% versus a loss of 35.3%. Lifeward is the larger company by market cap ($18.7 million vs $15.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | LFWD |
|---|---|---|
| Share price | $3.18 | $6.61 |
| Market cap | $15.40M | $18.72M |
| 1-day change | +4.61% | +3.04% |
| YTD return | -1.62% | -7.13% |
| 1-year return | -18.28% | -35.29% |
| 5-year return | — | -94.37% |
| EPS (TTM) | $-3.21 | $-15.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $9.84 |
| 52-week low | $1.63 | $4.14 |
| Distance from 52-week high | -39.43% | -32.83% |
| Analyst consensus | buy | none |
| Avg. price target upside | +277.36% | +202.57% |
| Average volume | 154.08K | 6.08K |
| Shares outstanding | 4.84M | 2.83M |
| Employees | 14 | 81 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HSCS has outperformed LFWD by 17.0 percentage points over the past year.
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Health Care · Industrial Specialties · 81 employees
HSCS vs LFWD FAQ
Which is bigger, HeartSciences or Lifeward?
Lifeward (LFWD) is larger, with a market capitalization of $18.72M compared with $15.40M for HeartSciences (HSCS).
Which stock has performed better over the past year, HSCS or LFWD?
HSCS returned -18.28% over the past 12 months, compared with -35.29% for LFWD (price return, excluding dividends). Past performance does not predict future results.
Are HeartSciences and Lifeward in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.